Regeneron to acquire 2seventy's cell therapy pipeline
BioPharma
Stay updated with breaking news from Chip Baird. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Activist investor Engine Capital on Wednesday urged 2seventy bio to appoint its current finance chief Chip Baird as the company's chief executive officer, in a letter sent to the cell and gene...
(Reuters) -Activist investor Engine Capital on Wednesday sent a letter to the board of cancer therapy developer 2seventy bio, urging a board refresh a...
Toronto-based artificial intelligence drug development startup Deep Genomics has hired Brian O’Callaghan to replace company founder Brendan Frey as CEO.
Approximately 40% workforce reduction combined with related actions expected to achieve $130+ million savings in the 2024-2025 period; projected cash runway into at least 2026 to support focus on...